Prosecution Insights
Last updated: May 29, 2026

Examiner: WOOLWINE, SAMUEL C

Tech Center 1600 • Art Units: 1634 1637 1656 1681

This examiner grants 61% of resolved cases

Performance Statistics

61.0%
Allow Rate
+1.0% vs TC avg
899
Total Applications
+20.0%
Interview Lift
1314
Avg Prosecution Days
Based on 847 resolved cases, 2023–2026

Rejection Statute Breakdown

4.0%
§101 Eligibility
7.4%
§102 Novelty
56.4%
§103 Obviousness
16.8%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18462354 METHODS OF IDENTIFYING COMBINATIONS OF TRANSCRIPTION FACTORS Non-Final OA President and Fellows of Harvard College
18130523 METHODS, COMPOSITIONS, KITS AND SYSTEMS FOR SIGNAL-ON DETECTION OF NEUTRALIZATION TARGETS Non-Final OA PRESIDENT AND FELLOWS OF HARVARD COLLEGE
17516215 METHOD OF OPTIMIZING EFFICACY OF THERAPEUTIC AGENT Non-Final OA Abbott Diabetes Care Inc.
17904301 Method and Device for Carrying out a qPCR Process Final Rejection Robert Bosch GmbH
18146748 NANOPHOTODETECTOR-BASED DEVICE FOR BIOMOLECULAR DETECTION Final Rejection Centre National de la Recherche Scientifique
18139829 HIGH SENSITIVITY IMMUNOASSAY Non-Final OA Bio-Rad Laboratories, Inc.
18547495 METHODS FOR PROGNOSING, DIAGNOSING, AND TREATING COLORECTAL CANCER Non-Final OA BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
18187488 OLIGONUCLEOTIDES ASSOCIATED WITH ANTIBODIES Final Rejection Becton, Dickinson and Company
17758415 TRANSPOSITION-BASED DIAGNOSTICS METHODS AND DEVICES Final Rejection THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
18308611 REVERSE TRANSCRIPTION-FREE QUANTITATIVE-DISCRETE POLYMERASE CHAIN REACTION FOR POST-PROCESS QUALITY CONTROL OF VESICULAR BIOLOGICS Non-Final OA Wayne State University
18261812 COMPOSITIONS, KITS AND METHODS FOR DIRECT AMPLIFICATION FROM CRUDE BIOLOGICAL SAMPLES Non-Final OA LIFE TECHNOLOGIES CORPORATION
18320411 ASSAY METHODS Non-Final OA MESO SCALE TECHNOLOGIES, LLC.
18384971 Microfluidic Analysis System Non-Final OA Stokes Bio Limited
18286957 OPTIMIZED OLIGONUCLEOTIDE TX PROBE FOR A MULTIPLEXING ANALYSIS OF NUCLEIC ACIDS AND A MULTIPLEXING METHOD Non-Final OA BIOTYPE GMBH
18370325 MULTI-PRIMER AMPLIFICATION METHOD FOR BARCODING OF TARGET NUCLEIC ACIDS Non-Final OA Fluidigm Corporation
18463607 Rare Cell Analysis Using Sample Splitting And DNA Tags Non-Final OA Verinata Health, Inc.
16630547 DNA TARGETS AS TISSUE-SPECIFIC METHYLATION MARKERS Final Rejection HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT LTD.
18351061 METHODS AND DEVICES FOR ULTRASENSITIVE DIRECT DETECTION OF MICROORGANISMS Non-Final OA HelixBind, Inc.
18030464 OLIGONUCLEOTIDES REPRESENTING DIGITAL DATA Non-Final OA Nucleotrace Pty. Ltd.
18004145 NUCLEIC ACID SEQUENCING METHOD AND APPARATUS Non-Final OA GENEUS TECHNOLOGIES (CHENGDU) CO., LTD.
17293412 ELECTRONIC DETECTION OF NUCLEIC ACID STRUCTURE Non-Final OA OMNIOME, INC.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month